Clinical trial Recruiting at 1 site Observational Ages 20 to 45 Women only

How anticoagulant medicines affect the uterine lining and pregnancy chances in women with infertility

Official title: Evaluation of the Effect of Anticoagulant Therapy on Endometrial Receptivity and Pregnancy Outcomes in Patients With Infertility Using an Ultrasound Multimodal System

Run by Tang-Du Hospital · NCT07494877 · Data updated 2026-11-12

This study will see if routine anticoagulant medicines like low-dose aspirin or heparin change endometrial receptivity and improve early pregnancy outcomes in women aged 20–45 with infertility.

More Infertility trials

Quick facts

Study typeObservational
Ages20 Years to 45 Years
SexWomen only
Enrollment300 (estimated)
SponsorTang-Du Hospital
Academic / other
Locations1 site (Xi'an, Shaanxi)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedNovember 30, 2027
Study endsDecember 31, 2027
Registry record updatedMarch 27, 2026
Trial IDNCT07494877 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 20–45 with a clinical diagnosis of infertility who are planning embryo transfer or monitored conception cycles and can undergo multimodal ultrasound during the implantation window are ideal candidates.

Probably not a fit

Patients with major congenital uterine anomalies, untreated significant intrauterine lesions, severe systemic illness, or known bleeding disorders are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, prospective observational cohort that will follow about 300 infertile women aged 20–45 who are planning embryo transfer or monitored conception cycles. Participants will be observed in two groups based on whether they receive routine anticoagulant therapy (for example, low-dose aspirin or heparin) as part of their clinical care, with no treatment decisions made by the study team. A multimodal ultrasound system (2D, 3D and Doppler) will be used to measure endometrial thickness, morphology, peristalsis, and blood flow indices during the implantation window. Pregnancy status and outcomes will be followed at roughly 45 and 90 days of gestation to compare ultrasound-based receptivity indicators and early pregnancy results between groups.

Why it matters

Potential benefit: If positive, the results could help clinicians decide when adding low-dose aspirin or heparin might improve endometrial blood flow and increase early pregnancy rates for some infertile women.

How similar studies have gone: Prior research on low-dose aspirin and heparin in infertility has shown mixed, condition-specific results with modest benefit mainly in selected groups (for example, recurrent implantation failure or certain thrombophilias), so effects are not definitively proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female patients aged 20 to 45 years.

Clinically diagnosed with infertility and planning to undergo embryo transfer or monitored conception cycles.

Patients who have complete baseline clinical data and are willing to undergo multimodal ultrasound evaluation of endometrial receptivity during the window of implantation.

Voluntarily agreed to participate in this observational study and signed the informed consent form for data collection.

Exclusion Criteria:

* Presence of congenital uterine malformations (e.g., septate uterus, bicornuate uterus, unicornuate uterus) that significantly alter the endometrial cavity.

Presence of untreated severe intrauterine lesions, such as submucosal fibroids, severe intrauterine adhesions, or endometrial polyps that may mechanically interfere with implantation.

Severe underlying systemic diseases, including but not limited to severe liver or kidney dysfunction, or malignant tumors.

Known severe bleeding disorders or strict contraindications to anticoagulant medications (for patients in the routine clinical care setting).

Patients who are unable to cooperate with the transvaginal multimodal ultrasound examination or complete the required follow-up for pregnancy outcomes.

Where it's running

  • Tangdu Hospital, Air Force Medical University
    Xi'an, Shaanxi, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.